These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29220199)

  • 1. Risk Factors for Gaps in Care during Transfer from Pediatric to Adult Cystic Fibrosis Programs in the United States.
    Sawicki GS; Ostrenga J; Petren K; Fink AK; D'Agostino E; Strassle C; Schechter MS; Rosenfeld M
    Ann Am Thorac Soc; 2018 Feb; 15(2):234-240. PubMed ID: 29220199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health outcomes associated with transition from pediatric to adult cystic fibrosis care.
    Tuchman L; Schwartz M
    Pediatrics; 2013 Nov; 132(5):847-53. PubMed ID: 24144711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transition programs in cystic fibrosis centers: perceptions of pediatric and adult program directors.
    Flume PA; Anderson DL; Hardy KK; Gray S
    Pediatr Pulmonol; 2001 Jun; 31(6):443-50. PubMed ID: 11389577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health insurance and use of recommended routine care in adults with cystic fibrosis.
    Li SS; Hayes D; Tobias JD; Morgan WJ; Tumin D
    Clin Respir J; 2018 May; 12(5):1981-1988. PubMed ID: 29356436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoothing the transition from pediatric to adult care: lessons learned.
    Flume PA
    Curr Opin Pulm Med; 2009 Nov; 15(6):611-4. PubMed ID: 19696678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of timing of transfer from pediatric- to adult-focused primary care.
    Wisk LE; Finkelstein JA; Sawicki GS; Lakoma M; Toomey SL; Schuster MA; Galbraith AA
    JAMA Pediatr; 2015 Jun; 169(6):e150951. PubMed ID: 26030515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a cystic fibrosis transition program from pediatric to adult care.
    Chaudhry SR; Keaton M; Nasr SZ
    Pediatr Pulmonol; 2013 Jul; 48(7):658-65. PubMed ID: 22888094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Transition Outcomes in Cystic Fibrosis: Analysis of National Patient Registry and CF RISE (Responsibility. Independence. Self-care. Education) Data.
    Melton K; Liu J; Sadeghi H; George M; Smaldone A
    J Pediatr; 2024 Feb; 265():113812. PubMed ID: 37918520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States.
    Schechter MS; Shelton BJ; Margolis PA; Fitzsimmons SC
    Am J Respir Crit Care Med; 2001 May; 163(6):1331-7. PubMed ID: 11371397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving transition from paediatric to adult cystic fibrosis care: programme implementation and evaluation.
    Okumura MJ; Ong T; Dawson D; Nielson D; Lewis N; Richards M; Brindis CD; Kleinhenz ME
    BMJ Qual Saf; 2014 Apr; 23 Suppl 1(0 1):i64-i72. PubMed ID: 24415776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transition program from pediatric to adult care for cystic fibrosis patients.
    Nasr SZ; Campbell C; Howatt W
    J Adolesc Health; 1992 Dec; 13(8):682-5. PubMed ID: 1290768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the affordable care act dependent coverage provision on patients with cystic fibrosis.
    Tumin D; Li SS; Kopp BT; Kirkby SE; Tobias JD; Morgan WJ; Hayes D
    Pediatr Pulmonol; 2017 Apr; 52(4):458-466. PubMed ID: 28152283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transition programs in cystic fibrosis centers: perceptions of team members.
    Flume PA; Taylor LA; Anderson DL; Gray S; Turner D
    Pediatr Pulmonol; 2004 Jan; 37(1):4-7. PubMed ID: 14679482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate of Uptake of Ivacaftor Use after U.S. Food and Drug Administration Approval among Patients Enrolled in the U.S. Cystic Fibrosis Foundation Patient Registry.
    Sawicki GS; Dasenbrook E; Fink AK; Schechter MS
    Ann Am Thorac Soc; 2015 Aug; 12(8):1146-52. PubMed ID: 26073026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transitions in Health Care: What Can We Learn from Our Experience with Cystic Fibrosis.
    West NE; Mogayzel PJ
    Pediatr Clin North Am; 2016 Oct; 63(5):887-97. PubMed ID: 27565366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of insurance instability on children's access, utilization, and satisfaction with health care.
    Cassedy A; Fairbrother G; Newacheck PW
    Ambul Pediatr; 2008; 8(5):321-8. PubMed ID: 18922506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of Health Insurance Coverage and Lung Disease Progression in Adolescents and Young Adults with Cystic Fibrosis.
    Tumin D; Crowley EM; Li SS; Wooten W; Ren CL; Hayes D
    Ann Am Thorac Soc; 2021 Feb; 18(2):290-299. PubMed ID: 32885982
    [No Abstract]   [Full Text] [Related]  

  • 18. Smoothing the transition of adolescents with CF from pediatric to adult care: Pre-transfer needs.
    Genovese VV; Perceval M; Buscarlet-Jardine L; Pinsault N; Gauchet A; Allenet B; Llerena C
    Arch Pediatr; 2021 May; 28(4):257-263. PubMed ID: 33863608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating barriers to and promoters of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs.
    Gifford AH; Ong T; Dowd C; Van Citters AD; Scalia P; Sabadosa KA; Sawicki GS
    J Cyst Fibros; 2021 Dec; 20 Suppl 3():9-13. PubMed ID: 34930545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving transition from pediatric to adult cystic fibrosis care: lessons from a national survey of current practices.
    McLaughlin SE; Diener-West M; Indurkhya A; Rubin H; Heckmann R; Boyle MP
    Pediatrics; 2008 May; 121(5):e1160-6. PubMed ID: 18450860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.